ABSTRACf. High doses of intravenous immunoglobulin were given to seven pregnant women between the 27th and 36th wk of gestation who were at risk for preterm delivery. Determinations of IgG subclasses and of antibodies against group B streptococcal serotypes, pneumococcal polysaccharides, and tetanus toxoid were done in maternal serum before and after intravenous IgG infusion and after delivery in cord serum. Substantial transplacental passage of the infused material could be observed in five cases where delivery occurred at the 34th wk or later. After the 36th wk of gestation, IgG subclass and antibody concentrations in cord serum were increased up to the levels in the maternal serum. (Pediatr Res 20:933-936, 1986) Abbreviation IGIV, intravenous immunoglobulin Preterm neonates are known to be highly susceptible to systemic bacterial infections (1). This increased risk is due in part to the immaturity of the immune system and to an incomplete transplacental transfer of protective IgG antibodies from the mother (2-7). Sidiropoulos et al. (8) have shown that the administration of IGIV in combination with antibiotics was effective in the treatment of neonatal sepsis, particularly in premature babies. As a consequence of this previous work, the question was asked whether perinatal or prenatal infection could be prevented by giving IGIV to pregnant women who were at risk for preterm delivery. As a first step, we studied the possibility of a transplacental passage of IGIV administered in the last trimenon of pregnancy. This report provides evidence that all four IgG subclasses and various specific antibodies present in the IGIV preparation are transferred from the mothers to the babies.
PATIENTSThe study included seven women between the 27th and the 36th wk of pregnancy who were at risk for preterm delivery with preterm labor, rupture of the membranes, or signs of chorioam- nionitis. The gestational age was assessed by serial ultrasonography and examination of the newborns. Informed consent was obtained from all women. Immunoglobulin applications consisted of intravenous infusions of 24 g IgG (Sandoglobulin) at each of5 consecutive days (6% solution in 0.9% saline, 10 drops/ min). In addition, the patients received the antibiotics amoxicillin (4 g/day) and clindamycin (1.8 g/day). Monitoring of pulse and blood pressure, cardiotocography, and clinical observation did not show any side effects attributable to IGIV in mothers and infants. Serum samples were obtained immediately before the first and after the last infusion. In three women in whom delivery was delayed for 8-25 days after the last infusion, additional samples were taken at the time of birth. Cord blood samples were collected at delivery. The serum was kept at -20 0 C until assayed.
METHODSIgG subclasses. IgG subclass specific reagents were prepared by immunizing sheep with isolated myeloma proteins and quantitative determinations were done with a solid phase radioimmunoassay as described (9, 10). Binding inhibition curves were established using the WHO r...